Background. In the United States, the proportion of patients with extrapulmonary tuberculosis (EPTB) has increased relative to cases of pulmonary tuberculosis. Patients with central nervous system (CNS)/meningeal and disseminated EPTB and those with human immunodeficiency virus (HIV)/AIDS have increased mortality. The purpose of our study was to determine risk factors associated with particular types of EPTB.
INTRODUCTION
Although the incidence of tuberculosis has been decreasing in the United States since 1993, the proportion of new tuberculosis cases that are extrapulmonary (EPTB) has increased [1, 2] . The proportional rise in EPTB cases has been associated with the human immunodeficiency virus (HIV)/AIDS epidemic because there is increased susceptibility for reactivation and dissemination of tuberculosis in these patients [3] . While this trend in EPTB incidence has been noted in both national public health surveillance data and in clinical case reviews, risk factors for specific types of EPTB have been understudied [1, 4, 5] . Risk factors for mortality in patients with EPTB include certain sites of disease (e.g., meningitis, disseminated) [6] ; other coexisting conditions, including HIV/AIDS [7, 8] ; low socioeconomic status [9, 10] ; and national origin [11, 12] . The complex relationship, however, between patient demographic characteristics, behavioral risk factors, clinical characteristics and comorbidities, and EPTB remains poorly understood. State and federal EPTB surveillance reporting does not include the depth of clinical information necessary to further investigate recognized trends in the epidemiology of EPTB [1, 4] .
HIV infection is now recognized as the most common risk factor associated with EPTB [13, 14] . Furthermore, severe immunosuppression (ie, low CD4 + T-cell counts), characteristic of advanced HIV infection, increases the odds of having EPTB versus pulmonary tuberculosis (PTB) alone [14] . However, a previous study at our institution demonstrated that the mortality of EPTB in HIV-infected patients is associated with more severe forms of EPTB [5, 7] . Previous studies have not used multivariable methods to determine if the association between HIV status and the site of EPTB disease is independent of other risk factors for EPTB and death. The primary objectives of this study were to (1) describe the clinical presentation of EPTB among patients at a large public hospital in a major metropolitan area of the southeastern United States (where prevalence of all forms of tuberculosis is known to be high [5, 15] ), and (2) determine which particular types of EPTB are independently associated with HIV infection. A secondary objective was to assess whether CD4 lymphocyte count is independently associated with particular types of EPTB among HIV-infected EPTB patients.
METHODS

Study Population
A retrospective study was performed that included all cases of EPTB diagnosed between 1 January 1995 and 31 December 2007 at a 1000-bed inner-city public teaching hospital. A case of EPTB was defined as any patient with culture positive or clinical diagnosis of tuberculosis at a site outside of the lung parenchyma (eg, central nervous system [CNS], disseminated, lymphatic, or pleural). Cases of EPTB were identified through the hospital's surveillance system for tuberculosis (based on laboratory results for AFB smear and culture) as well as clinical cases identified and reported by physicians at the hospital. All cases were reported to local and state health departments and met American Thoracic Society criteria for diagnosis of tuberculosis [16] . For all cases, identified records and laboratory results were collected from the hospital and the patient's county health department. Patients less than 18 years of age were excluded. Information from each case collected included demographics and behavioral risk factors for tuberculosis, HIV status, site of disease, prior history of active tuberculosis, diagnostic radiology, smear and culture results, and 12-month outcome.
Case Definitions
Cases of EPTB were classified by disease location using standards set forth by the American Thoracic Society and Centers for Disease Control and Prevention [16] . Severe EPTB disease was categorized as either CNS/meningeal and/or disseminated disease. Disseminated disease was defined as any patient with a positive culture for Mycobacterium tuberculosis at two distinct extrapulmonary sites or a patient with a blood culture positive for M. tuberculosis. Focal disease was defined as pleural, bone, gastrointestinal (GI), or genitourinary (GU). Pulmonary disease (other than tuberculosis) included noninfectious lung findings (chronic obstructive pulmonary disease, lung cancer, interstitial lung disease). HIV infection was determined by a serum enzyme-linked immunosorbent assay (ELISA) with confirmation by Western blot. A CD4 lymphocyte count <100 cells/µL was considered "low." Concomitant PTB was defined as having a positive respiratory specimen culture for M. tuberculosis or a clinical diagnosis of PTB based on radiologic evidence and exclusion of other causes [16] ; these patients were included in analyses. Chest radiographic findings were abstracted from final radiology reports.
Clinical characteristics were abstracted from the hospital medical records and 212 cases were included from a previous study at this institution [17] . Patient characteristics (eg, regular alcohol use, illicit drug use, history of incarceration, etc.) were taken from the clinician's reporting of these factors in the medical record. At the time of hospitalization, clinicians used the institution's standard substance abuse screening tools and prior documented substance abuse history when including such descriptive labels in the patient care record. Mortality data were obtained from reviewing the hospital medical records as well as the patient's local county health department tuberculosis program medical records, which was cross-referenced with death certificates. The study was approved by the Emory University Institutional Review Board, the Grady Health System Research Oversight Committee, and the Georgia Department of Human Resources Institutional Review Board.
Statistical Analysis
Data were abstracted using a standardized form and entered into EpiInfo 3.5.1 software (Centers for Disease Control and Prevention, Atlanta, GA). Data analyses were carried out using IBM SPSS Statistics 19 (IBM Corporation, Somers, NY) and SAS 9.2 (Cary, NC). To assess univariate associations for categorical variables, Pearson χ 2 tests were calculated comparing the expected outcome of patient characteristics (the total population) as compared to the observed outcome within each site of disease; for continuous variables, analysis of variance was used to compare differences in means by site of disease. A P value >.05 was considered statistically significant throughout the analyses. To assess independent associations between demographics, clinical and behavioral characteristics (including HIV and CD4 counts) with site of EPTB disease, nonordered multinomial logistic regression models were constructed to estimate crude odds ratios (CORs), adjusted odds ratios (AORs), and 95% confidence intervals (CIs). Lymphatic EPTB was chosen as the referent group in the nonordinal regression analyses. Adjusted models controlled for known confounders, demographic characteristics, and covariates that were significantly associated with EPTB in the univariate analysis. A sensitivity analysis was performed to rule out significant changes in results when HIV-status-unknown patients were categorized as all infected or all uninfected.
RESULTS
Three hundred twenty cases of EPTB were identified during the 12-year study period. During the study period, the mean number of cases of EPTB was 24 per year (range 12-35/year) at this institution. The majority of patients with EPTB patients were male (68%) and black (82%), and the median age was 38 years (mean 40, range 18-89 years). Forty-eight percent (154/ 320) of patients with EPTB were HIV infected, 46% percent were HIV uninfected, and 6% had unknown HIV status. Only 13% of HIV-infected patients were on highly active antiretroviral therapy (HAART), and the mortality of HIV-infected patients with EPTB was 21% (with 97% of these not on HAART at the time of EPTB diagnosis). Of patients who were HIV infected, 78% were male, 84% were black, and 17% were foreign-born. Of patients who were black, 67% were male, 52% were HIV infected, and 85% were US-born. Forty percent (127/320) of all EPTB cases had concomitant PTB. Most patients (94%) were hospitalized at the time of diagnosis and the mean duration of inpatient stay was 22.1 days (36.0 standard deviation).
The distribution of site of disease by the study population characteristics is shown in Table 1 . The most common sites of extrapulmonary disease were lymphatic (28%), meningeal (22%), and disseminated tuberculosis (28%). In the univariate analysis, site of EPTB disease was significantly associated with birthplace, duration of inpatient stay, concomitant pulmonary tuberculosis disease, 12-month mortality, normal chest X-ray, HIV status, and alcohol use (P value <.05; Table 1 ). The number of patients with concomitant PTB was higher in individuals with disseminated disease (63.5%) or pleural disease (48.9%) as compared to the overall percentage of the study population (39.7%). The overall mortality among patients with EPTB was 14.7% (among the 300 patients who had mortalityrelated data available). Mortality was significantly higher among those with CNS/meningeal disease (20%) and significantly lower among those with pleural (4.4%) and lymphatic (4.5%) disease as compared to the entire cohort of patients with EPTB. Patients with CNS/meningeal (60.0%) and disseminated tuberculosis (58.1%) were more likely to have HIV and less likely to have pleural tuberculosis (20.0%). Patients with CNS/meningeal (51.6%) and disseminated (47.8%) sites were significantly more likely to have hospital stays greater than 14 days compared to the entire cohort (39.3%). Alcohol use was noted in 130 patients (40.8%); a higher percentage of EPTB patients with pleural disease (55.5%) and a lower percentage of patients with lymphatic reported alcohol use compared to expected results.
Multivariable analyses were performed in order to identify independent associations between demographics, clinical characteristics, and behaviors with EPTB disease location (Table 2) . HIV-infected patients were less likely (AOR 0.3; 95% CI .2, .6) to have a site of disease categorized as pleural as compared to lymphatic (Table 2) . Patients with concomitant PTB were more likely to have disseminated (AOR 1.9, 95% CI 1.3, 2.8) EPTB and less likely to have CNS/meningeal EPTB (AOR 0.6, 95% CI 0.4, 0.9) than lymphatic EPTB.
Median CD4 lymphocyte counts were evaluated for EPTB patients who were also HIV infected. In the multivariable model, EPTB-HIV patients with CD4 <100 were more likely (AOR 1.6; 95% CI 1.0, 2.4) to have "severe" sites of disease (eg. CNS/meningeal and disseminated) compared to lymphatic EPTB (Table 3) . Other characteristics among patients with HIV infection that were evaluated were not significant in univariate analysis or independently associated with EPTB disease location in multivariable analysis.
DISCUSSION
In this study, multivariable analyses of 320 patients with EPTB demonstrated that CNS/meningeal (as compared to lymphatic) was inversely and independently associated with concomitant PTB, while disseminated was positively associated with concomitant PTB. Unlike prior studies [5, 7] , this analysis controlled for a diverse array of demographic, clinical, and behavioral characteristics that could potentially affect the site of EPTB disease. HIV status was available for 94.4% of EPTB patients, another strength of our study. We demonstrated that pleural site of disease was inversely and independently associated with HIV infection. Among HIV-infected patients, severe forms of EPTB (CNS/meningeal and disseminated) were independently associated with CD4 lymphocyte counts >100.
Our findings are consistent with other studies that examine factors associated with site of EPTB. For example, in univariate analyses, we found that HIV infection was significantly associated with site of EPTB disease. Similar to other studies [4, 17] , we found that HIV-infected patients with EPTB were less likely to have pleural as their site of disease than HIV-uninfected patients (5.8% versus 22.3%). After adjusting for factors significant in the univariate analysis, HIV-infected patients were less likely (AOR 0.3; 95% CI .2, .6) to have site of disease categorized as pleural than lymphatic relative to HIV-uninfected patients.
Foreign birth has also been shown to be associated with site of EPTB [4, 18] . We found birthplace to be significantly associated with site of EPTB in univariate analyses. For instance, 5.3% (4/76) of foreign-born EPTB patients had pleural site of disease compared to 16.8% (41/244) of US-born EPTB patients. Lymphatic site of disease was more common among foreign-born EPTB patients than US-born patients (43.4% versus 22.9%). Kipp et al. [4] found a similar trend with cervical lymphatic site of disease (29.6% in foreign-born versus 10.0% in US-born patients). However, in our study, after adjusting for significant factors in the univariate analyses (including HIV), birthplace was not independently associated with site of EPTB disease.
Other studies have demonstrated associations between EPTB and concomitant PTB [19, 20] . We showed that the adjusted odds of having disseminated (versus lymphatic) site of EPTB among patients with concomitant PTB was 1.9 (95% CI 1.3, 2.8) times the odds as among patients without PTB. Previous studies have demonstrated that among HIVinfected patients with tuberculosis, having EPTB-compared to PTB-was associated with lower CD4 lymphocyte counts. After adjusting for demographic, clinical, and behavioral characteristics, we found that HIV patients with EPTB and CD4 < 100 were more likely (AOR 1.6; 95% CI 1.0, 2.4) to have CNS/meningeal or disseminated EPTB compared to lymphatic EPTB. This finding contrasts a previous study by Kingkaew et al. [7] , which showed that among patients with HIV, 71.8% of those with severe EPTB sites (meningeal/disseminated) had CD4 lymphocyte counts <100, nearly the same proportion (71.0%) as lymphatic EPTB patients had CD4 <100.
The relationship between lower CD4 lymphocyte counts and site of EPTB disease is consistent with presumed clinical pathogenesis to more severe forms of EPTB [21] . Although these results are consistent with current clinical rationale, epidemiologic evidence has previously been lacking. Earlier studies hypothesized that declining CD4 lymphocyte counts would be associated with increasingly severe variants of EPTB, but this remained underinvestigated [14, 22] . For example, it is known that circulating levels of antituberculosis antibody production [23, 24] , decreased T-lymphocyte activation [24] , and interferon-γ [25] are decreased in HIV-infected patients with tuberculosis, which increases the risk of tuberculosis reactivation [26] . Our study intends to highlight that early consideration of extrapulmonary tuberculosis in patients with pulmonary tuberculosis and HIV-infected patients with CD4 < 100 is important in order to reduce mortality and morbidity with administration of antitubercular treatment.
Limitations
Our study was subject to potential limitations. The crosssectional nature of the study design prohibited inference regarding the temporal relationship of the associations observed. Misclassification of our primary and secondary exposures of interest (HIV status and CD4 lymphocyte count) was possible since CD4 lymphocyte count varies over time. We did not have a standard time interval for CD4 measurement among HIV patients, our classification of "low" and "normal" CD4 may be incorrectly categorized because they were measured in the acute setting of EPTB disease. Future research is needed to determine if CD4 lymphocyte count (or other measure of immunity) is independently associated with severe sites of infection among HIV-uninfected patients. This study also utilized an observational design, and therefore reported crude and adjusted odds ratios could be biased due to unmeasured or unknown confounders. However, based on previously published studies [1, 7, 19] , our multivariable analyses were able to include measures previously reported to be associated with both HIV and site of EPTB. This study was conducted in large US metropolitan area with a large proportion of low-income, foreign-born, and HIV-infected patients hospitalized with EPTB. The extent to which the reported findings are generalizable to other populations is Bold indicates χ 2 P < .05.
Abbreviations: CI, confidence interval; CNS, central nervous system; HIV, human immunodeficiency virus; PTB, pulmonary tuberculosis. a Adjusted for age, sex, race, and all variables in the table.
b Severe includes CNS, meningeal, and disseminated EPTB.
c Focal includes pleural, bone, joint, gastrointestinal, genitourinary.
unknown, but vigilance for severe forms of EPTB in HIV patients is relevant regardless of the setting.
Conclusions
This study describes the largest known case series of EPTB at a large urban hospital collected during the post-highly active antiretroviral therapy (HAART) era. The study is important because of the patient demographics, which include a majority of patients who were US-born (76%) and black (82%) with HIV infection (48.1%) in the post-HAART era. When controlling for other clinical factors, HIV infection was associated with more severe forms of EPTB disease (eg, CNS/meningeal and disseminated disease). Among HIV patients, this risk of more severe EPTB forms was further increased in patients with low CD4 counts. Although prospectively designed studies will ultimately be needed to demonstrate an improvement among individuals who can maintain high CD4 counts, continuing to improve chronic HIV disease management and routinely keeping these severe forms of EPTB in clinical consideration are two means of improving outcomes for patients diagnosed with EPTB.
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